News For MMC From The Last 14 Days Check below for free stories on MMC the last two weeks.
There are 4 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 9, 2010
|
| 15:41 EDT |  | MMC |
| theflyonthewall.com: | Companies reporting Before the Market Open on Wednesday, February 10 | | Notable companies reporting before the opening bell include Coca-Cola Enterprises (CCE), Computer Sciences (CSC), Dean Foods (DF), Intercontinental Exchange (ICE), Marsh & McLennan (MMC), Omnicom Group (OMC), Scripps Networks Interactive (SNI), Sprint Nextel (S), The New York Times (NYT), and Wyndham Worldwide (WYN). :theflyonthewall.com |
| | 14:28 EDT |  | MMC |
| theflyonthewall.com: | Marsh & McLennan: Earnings release technical preview, high gap risk | | BULLISH CASE: On better than expected news/outlook the stock could trade to the upper limit of the neutral price channel at $22.33. On a bullish breakout above the price channel the following resistance levels would become upside objectives: $23.06, $23.42, $23.79, $24.16, $24.53, $24.93, $25.31, $25.87, $26.50. BEARISH CASE: On worse than expected news/outlook the stock could trade to the lower limit of the price channel at $21.92. On a bearish breakdown below the price channel the following support levels would become downside objectives: $21.19, $20.81, $20.53, $19.85, $19.50, $19.17, $18.83, $18.46, $18.13. NOTE: Small short-base at 2 says to cover, with 1.5% of the float short. Traders are positioned for positive news. Reactions on a surprise, especially a negative one given the small short-base, have a high probability of being extreme in duration and price. High gap risk. :theflyonthewall.com |
|
|
February 3, 2010
|
| 17:29 EDT |  | MMC |
| theflyonthewall.com: | Inverness Medical to acquire Marsh & McLennan subsidiary Knoll Labs | | Inverness Medical Innovations (IMA) has entered into a binding agreement with Kroll, a subsidiary of Marsh and McLennan (MMC) to purchase its substance abuse testing division. The purchase price is $110M cash subject to a customary working capital adjustment. The acquisition is expected to close in 1Q10 but remains subject to customary closing conditions. :theflyonthewall.com |
|
|
February 2, 2010
|
| 11:44 EDT | | MMC |
|
|
|
Subscribe for More Information